View Press Releases
-
Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs
MOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new drugs
Sep 27, 2018
-
Thermo Fisher Scientific Expands Genome Editing IP Portfolio
CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio
Sep 26, 2018
-
Qlucore AB announces changes to Board of Directors
GUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at Ericsson
Sep 26, 2018
-
Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care
PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients
Sep 26, 2018
-
LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare
CAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 - Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reports
Sep 25, 2018
-
Quanticate partners with CluePoints™ to offer Data Quality Oversight
LONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines
Sep 25, 2018
-
BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston
WESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 a
Sep 24, 2018
-
ABclonal Technology Unveils Next-Generation Sequencing Kits For Illumina Sequencing Platforms
BOSTON, MA, UNITED STATES - Sep 13, 2018 - ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation sequencing library preparation kits (NGS lib prep kits), one of the industrys highest-yielding DNA and RNA library preparation kits
Sep 20, 2018
-
H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half
NEW YORK CITY, NY, US - Sep 20, 2018 - FOR IMMEDIATE RELEASE Media contact:Michelle Faulkner
Sep 20, 2018
+1 617-510-6998
michelle@big-swing
-
Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally
NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 20, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technology
Sep 20, 2018
-
Domainex appoints Dr Trevor Perrior as Chief Executive Officer
CAMBRIDGE, UK - Sep 20, 2018 - Domainex Ltd, a privately-owned drug research services company, is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018
Sep 20, 2018
-
Novel deep learning drug discovery platform gets £1 million innovation boost
, UK - Sep 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project
Sep 19, 2018
-
Rho Recruiting New Team Members at SOCRA Annual Conference
CHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT: Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018
Sep 18, 2018
-
Celebrating 10 Years of Sekisui XenoTech
KANSAS CITY, KS, UNITED STATES - Sep 18, 2018 - 10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assured
Sep 18, 2018
-
Creative Biolabs Illustrated Its Newly-developed Antibody Affinity Maturation Service
SHIRLEY, NY - Sep 18, 2018 - Sep 18th, 2018, Creative Biolabs, as one of the most experienced supplier in various antibody production and engineering fields, has recently released its newly-developed affinity maturation antibody, which is an indispensable process to improve antibody affinity for an antigen
Sep 17, 2018
-
LifeArc® announces new CEO appointment
LONDON - Sep 17, 2018 - London, UK, September 4th, 2018. LifeArc, one of the UK's leading medical research charities, is delighted to announce the appointment of Melanie Lee, PhD, CBE as its new Chief Executive Officer (CEO), effective 1st November 2018
Sep 17, 2018
-
Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry
CAMBRIDGE AND ONGAR, UK - Sep 17, 2018 - A paper entitled Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry
Sep 17, 2018
-
Creative Diagnostics Launches Recombinant HPV L1 VLP for Science Research
SHIRLEY, NY, UNITED STATES - Sep 17, 2018 - As a leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics now establishes a global-leading virus-like particles (VLPs) manufacture platform using Ex
Sep 17, 2018
-
Particle Sciences appoints new president
MANCHESTER, UNITED KINGDOM - Sep 13, 2018 - BETHLEHEM, PA, September 13th, 2018 - Particle Sciences, a Lubrizol LifeSciences company and leading pharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of Dr
Sep 13, 2018
-
Recipharm connects to European Hub for serialisation compliance
STOCKHOLM, SWEDEN - Sep 13, 2018 - Recipharm, a leading contract development and manufacturing organisation (CDMO) has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub
Sep 13, 2018